<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wang Y</submitter><funding>Young Scientific and Technological Talents Support Project of Jilin Province</funding><funding>MOST | National Natural Science Foundation of China (NSFC)</funding><funding>China Postdoctoral Science Foundation</funding><funding>MOST | National Natural Science Foundation of China</funding><funding>China Postdoctoral Science Foundation (China Postdoctoral Foundation Project)</funding><pagination>2368-2396</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11183095</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>43(12)</volume><pubmed_abstract>Phosphoglycerate mutase 1 (PGAM1) is a key node enzyme that diverts the metabolic reactions from glycolysis into its shunts to support macromolecule biosynthesis for rapid and sustainable cell proliferation. It is prevalent that PGAM1 activity is upregulated in various tumors; however, the underlying mechanism remains unclear. Here, we unveil that pyruvate kinase M2 (PKM2) moonlights as a histidine kinase in a phosphoenolpyruvate (PEP)-dependent manner to catalyze PGAM1 H11 phosphorylation, that is essential for PGAM1 activity. Moreover, monomeric and dimeric but not tetrameric PKM2 are efficient to phosphorylate and activate PGAM1. In response to epidermal growth factor signaling, Src-catalyzed PGAM1 Y119 phosphorylation is a prerequisite for PKM2 binding and the subsequent PGAM1 H11 phos</pubmed_abstract><journal>The EMBO journal</journal><pubmed_title>PKM2 functions as a histidine kinase to phosphorylate PGAM1 and increase glycolysis shunts in cancer.</pubmed_title><pmcid>PMC11183095</pmcid><funding_grant_id>32070896</funding_grant_id><funding_grant_id>2020T130090</funding_grant_id><funding_grant_id>32070758</funding_grant_id><funding_grant_id>32101048</funding_grant_id><funding_grant_id>QT202105</funding_grant_id><funding_grant_id>2019M661190</funding_grant_id><pubmed_authors>Liu J</pubmed_authors><pubmed_authors>Jin X</pubmed_authors><pubmed_authors>Peng W</pubmed_authors><pubmed_authors>Tian M</pubmed_authors><pubmed_authors>Hao M</pubmed_authors><pubmed_authors>Feng Y</pubmed_authors><pubmed_authors>Ba X</pubmed_authors><pubmed_authors>Shu H</pubmed_authors><pubmed_authors>Zhao Z</pubmed_authors><pubmed_authors>Wang L</pubmed_authors><pubmed_authors>Zhang W</pubmed_authors><pubmed_authors>Wei M</pubmed_authors><pubmed_authors>Xia M</pubmed_authors><pubmed_authors>Dong K</pubmed_authors><pubmed_authors>Hao F</pubmed_authors><pubmed_authors>Xia C</pubmed_authors><pubmed_authors>Qu Y</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Di Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>PKM2 functions as a histidine kinase to phosphorylate PGAM1 and increase glycolysis shunts in cancer.</name><description>Phosphoglycerate mutase 1 (PGAM1) is a key node enzyme that diverts the metabolic reactions from glycolysis into its shunts to support macromolecule biosynthesis for rapid and sustainable cell proliferation. It is prevalent that PGAM1 activity is upregulated in various tumors; however, the underlying mechanism remains unclear. Here, we unveil that pyruvate kinase M2 (PKM2) moonlights as a histidine kinase in a phosphoenolpyruvate (PEP)-dependent manner to catalyze PGAM1 H11 phosphorylation, that is essential for PGAM1 activity. Moreover, monomeric and dimeric but not tetrameric PKM2 are efficient to phosphorylate and activate PGAM1. In response to epidermal growth factor signaling, Src-catalyzed PGAM1 Y119 phosphorylation is a prerequisite for PKM2 binding and the subsequent PGAM1 H11 phos</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jun</publication><modification>2026-06-01T11:21:43.66Z</modification><creation>2024-10-15T14:29:32.117Z</creation></dates><accession>S-EPMC11183095</accession><cross_references><pubmed>38750259</pubmed><doi>10.1038/s44318-024-00110-8</doi></cross_references></HashMap>